MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression

MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eu...

Full description

Saved in:
Bibliographic Details
Published inMolecular human reproduction Vol. 18; no. 3; pp. 136 - 145
Main Authors Dai, Lan, Gu, Liying, Di, Wen
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.03.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis.
AbstractList MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis.
MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis.MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis.
MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis.
Author Gu, Liying
Dai, Lan
Di, Wen
AuthorAffiliation 2 Shanghai Key Laboratory of Gynecologic Oncology , Focus Construction Subject of Shanghai Education Department , Shanghai , People's Republic of China
1 Department of Obstetrics and Gynecology , Renji Hospital, Shanghai Jiaotong University School of Medicine , 1630 Dong Fang Rd., Shanghai 200127, People's Republic of China
AuthorAffiliation_xml – name: 1 Department of Obstetrics and Gynecology , Renji Hospital, Shanghai Jiaotong University School of Medicine , 1630 Dong Fang Rd., Shanghai 200127, People's Republic of China
– name: 2 Shanghai Key Laboratory of Gynecologic Oncology , Focus Construction Subject of Shanghai Education Department , Shanghai , People's Republic of China
Author_xml – sequence: 1
  givenname: Lan
  surname: Dai
  fullname: Dai, Lan
  organization: Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, People's Republic of China
– sequence: 2
  givenname: Liying
  surname: Gu
  fullname: Gu, Liying
– sequence: 3
  givenname: Wen
  surname: Di
  fullname: Di, Wen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21989168$$D View this record in MEDLINE/PubMed
BookMark eNpVkc1u1TAQhS3Uiv7QJVvkHatwbcfXsTdIUFGo2lKpoutoEk9uDIkdbOdCX4KHYclD9JlI1RaV1RmdOfqONHNAdnzwSMhLzt5wZsrVGAbs42oDkSn1jOxzqVghJKt2nsx75CClr4zxSqz1c7InuNGGK71Pfl24q4IbAxRyRj9DxkTR2zBijg4GmnIM46ItDgN1fgvJbdFjSjT3McybnqZ5muJiuOBp6BYb6enZ2e3v1eeT4vbPezpB7n_ADQVvaUQ7t2gXUMY44PzN-UJT_PkIeEF2OxgSHj3oIbk--fDl-FNxfvnx9PjdeTFxzXIh0AreVqpTGkrdQScaYZhWsmkqpo2QHdcWJLeVKi22FbPCNEaAkYILubblIXl7z53mZkTbos8RhnqKboR4Uwdw9f8b7_p6E7Z1KYwozXoBvH4AxPB9xpTr0aW7G4HHMKd6Sa0rxaVckq-eVv3rePxB-RdN_5DT
ContentType Journal Article
Copyright The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2011
Copyright_xml – notice: The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2011
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1093/molehr/gar066
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1460-2407
EndPage 145
ExternalDocumentID PMC3292395
21989168
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-E4
.2P
.GJ
.I3
0R~
123
18M
29M
2WC
4.4
482
48X
53G
5WA
5WD
70D
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
ABDFA
ABEJV
ABEUO
ABGNP
ABIME
ABIXL
ABJNI
ABKDP
ABMNT
ABNGD
ABNHQ
ABNKS
ABPIB
ABPQP
ABPTD
ABQLI
ABQTQ
ABSMQ
ABVGC
ABWST
ABXVV
ABXZS
ABZBJ
ABZEO
ACFRR
ACGFO
ACGFS
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACZBC
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZTZ
AEGPL
AEHUL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFQV
AFFZL
AFGWE
AFIYH
AFOFC
AFSHK
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJDVS
AJEEA
AJNCP
AKHUL
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
ANFBD
APIBT
APJGH
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ATDFG
ATGXG
ATTQO
AVNTJ
BAYMD
BCRHZ
BEYMZ
BQDIO
BSWAC
BTRTY
BVRKM
BZKNY
CAG
CDBKE
CGR
COF
CS3
CUY
CVF
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
ECM
EE~
EIF
EIHJH
EJD
ELUNK
EMOBN
F5P
F9B
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HH5
HVGLF
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KOP
KQ8
KSI
KSN
M-Z
M49
MBLQV
MBTAY
N9A
NGC
NLBLG
NOMLY
NOYVH
NPM
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
OBFPC
OBOKY
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
SV3
TCN
TEORI
TJX
TLC
TMA
TR2
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
~S-
7X8
AGORE
AJBYB
5PM
ID FETCH-LOGICAL-p180t-2ed21c76f68a38faf2b290864bb708924f18da41d763dec70d29b92a9421245d3
ISSN 1460-2407
1360-9947
IngestDate Thu Aug 21 14:30:07 EDT 2025
Fri Jul 11 05:20:07 EDT 2025
Thu Apr 03 07:07:47 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p180t-2ed21c76f68a38faf2b290864bb708924f18da41d763dec70d29b92a9421245d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Lan Dai and Liying Gu contributed equally to this work.
PMID 21989168
PQID 923576144
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3292395
proquest_miscellaneous_923576144
pubmed_primary_21989168
PublicationCentury 2000
PublicationDate 2012-03-00
PublicationDateYYYYMMDD 2012-03-01
PublicationDate_xml – month: 03
  year: 2012
  text: 2012-03-00
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Molecular human reproduction
PublicationTitleAlternate Mol Hum Reprod
PublicationYear 2012
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References 18632614 - Cancer Res. 2008 Jul 15;68(14):5619-27
18408758 - Oncogene. 2008 Aug 7;27(34):4712-23
18710704 - Fertil Steril. 2009 May;91(5 Suppl):2148-56
12554859 - RNA. 2003 Feb;9(2):175-9
19683430 - Eur J Cancer. 2009 Sep;45(14):2618-27
12624257 - Science. 2003 Mar 7;299(5612):1540
17483545 - Mol Hum Reprod. 2007 Jul;13(7):503-9
17028437 - Gynecol Obstet Invest. 2007;63(2):71-97
20188363 - Fertil Steril. 2010 Nov;94(6):1985-94
19589872 - Endocrinology. 2009 Oct;150(10):4734-43
21436242 - Chest. 2011 Oct;140(4):980-90
20300586 - J Biomed Biotechnol. 2010;2010:369549
20400975 - Oncogene. 2010 Jun 17;29(24):3545-53
21268001 - Eur J Immunol. 2011 Feb;41(2):306-12
19446316 - Gynecol Oncol. 2009 Aug;114(2):253-9
19010917 - Cancer Res. 2008 Nov 15;68(22):9423-32
17575287 - Hum Reprod Update. 2007 Sep-Oct;13(5):487-99
19773286 - Hum Reprod Update. 2010 Mar-Apr;16(2):142-65
21030494 - Mol Hum Reprod. 2011 Mar;17(3):175-81
18791135 - J Anim Sci. 2009 Apr;87(14 Suppl):E29-38
20561612 - Fertil Steril. 2010 Dec;94(7):2942-4
18314120 - Fertil Steril. 2009 Mar;91(3):687-93
21436257 - Mol Endocrinol. 2011 May;25(5):821-32
21383689 - Oncogene. 2011 Aug 4;30(31):3404-15
20624982 - Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13450-5
10453354 - Endocr Rev. 1999 Aug;20(4):435-59
10499541 - Endocrinology. 1999 Oct;140(10):4809-20
18684450 - Fertil Steril. 2009 May;91(5 Suppl):2185-92
18941111 - Blood. 2009 Jan 8;113(2):396-402
17766684 - Mol Hum Reprod. 2007 Nov;13(11):797-806
10439007 - Fertil Steril. 1999 Aug;72(2):336-40
19088369 - Reprod Sci. 2008 Dec;15(10):993-1001
20103651 - Cancer Res. 2010 Feb 1;70(3):1063-71
21292970 - Science. 2011 Feb 4;331(6017):550-3
19892605 - J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):21-5
7962366 - Hum Reprod. 1994 Jun;9(6):1001-2
19651637 - Mol Hum Reprod. 2009 Oct;15(10):587-607
12496258 - J Biol Chem. 2003 Mar 7;278(10):8508-15
18688027 - Am J Pathol. 2008 Sep;173(3):700-15
18560586 - PLoS One. 2008;3(6):e2436
21266580 - J Biol Chem. 2011 Mar 25;286(12):10483-94
15690968 - Wien Klin Wochenschr. 2004 Dec 30;116(24):839-43
9543141 - J Clin Endocrinol Metab. 1998 Apr;83(4):1201-5
10087424 - Gynecol Obstet Invest. 1999;47 Suppl 1:18-20; discussion 20-2
17175059 - Lung Cancer. 2007 Apr;56(1):25-33
15541453 - Lancet. 2004 Nov 13-19;364(9447):1789-99
19692421 - Mol Hum Reprod. 2009 Oct;15(10):625-31
19398263 - Cancer Lett. 2009 Oct 8;283(2):159-67
20573927 - N Engl J Med. 2010 Jun 24;362(25):2389-98
21245828 - Nat Rev Genet. 2011 Feb;12(2):99-110
10488062 - J Biol Chem. 1999 Sep 24;274(39):27339-42
20799954 - Mol Cancer. 2010;9:227
20627991 - Mol Hum Reprod. 2010 Nov;16(11):818-34
14708018 - Nat Rev Drug Discov. 2004 Jan;3(1):17-26
21048306 - Biol Pharm Bull. 2010;33(11):1822-7
18451233 - Clin Cancer Res. 2008 May 1;14(9):2690-5
20424119 - Cancer Res. 2010 May 15;70(10):4005-14
19074548 - Mol Endocrinol. 2009 Feb;23(2):265-75
15019828 - Fertil Steril. 2004 Mar;81 Suppl 1:904-11
21335415 - Hum Reprod. 2011 May;26(5):1082-90
References_xml – reference: 18684450 - Fertil Steril. 2009 May;91(5 Suppl):2185-92
– reference: 21268001 - Eur J Immunol. 2011 Feb;41(2):306-12
– reference: 21436257 - Mol Endocrinol. 2011 May;25(5):821-32
– reference: 15690968 - Wien Klin Wochenschr. 2004 Dec 30;116(24):839-43
– reference: 20624982 - Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13450-5
– reference: 20400975 - Oncogene. 2010 Jun 17;29(24):3545-53
– reference: 20188363 - Fertil Steril. 2010 Nov;94(6):1985-94
– reference: 21436242 - Chest. 2011 Oct;140(4):980-90
– reference: 10453354 - Endocr Rev. 1999 Aug;20(4):435-59
– reference: 14708018 - Nat Rev Drug Discov. 2004 Jan;3(1):17-26
– reference: 10488062 - J Biol Chem. 1999 Sep 24;274(39):27339-42
– reference: 18632614 - Cancer Res. 2008 Jul 15;68(14):5619-27
– reference: 20300586 - J Biomed Biotechnol. 2010;2010:369549
– reference: 20561612 - Fertil Steril. 2010 Dec;94(7):2942-4
– reference: 18791135 - J Anim Sci. 2009 Apr;87(14 Suppl):E29-38
– reference: 12624257 - Science. 2003 Mar 7;299(5612):1540
– reference: 20573927 - N Engl J Med. 2010 Jun 24;362(25):2389-98
– reference: 18408758 - Oncogene. 2008 Aug 7;27(34):4712-23
– reference: 21245828 - Nat Rev Genet. 2011 Feb;12(2):99-110
– reference: 19892605 - J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):21-5
– reference: 19088369 - Reprod Sci. 2008 Dec;15(10):993-1001
– reference: 10439007 - Fertil Steril. 1999 Aug;72(2):336-40
– reference: 19010917 - Cancer Res. 2008 Nov 15;68(22):9423-32
– reference: 21335415 - Hum Reprod. 2011 May;26(5):1082-90
– reference: 19773286 - Hum Reprod Update. 2010 Mar-Apr;16(2):142-65
– reference: 21048306 - Biol Pharm Bull. 2010;33(11):1822-7
– reference: 17028437 - Gynecol Obstet Invest. 2007;63(2):71-97
– reference: 20424119 - Cancer Res. 2010 May 15;70(10):4005-14
– reference: 18688027 - Am J Pathol. 2008 Sep;173(3):700-15
– reference: 20627991 - Mol Hum Reprod. 2010 Nov;16(11):818-34
– reference: 17766684 - Mol Hum Reprod. 2007 Nov;13(11):797-806
– reference: 21030494 - Mol Hum Reprod. 2011 Mar;17(3):175-81
– reference: 21383689 - Oncogene. 2011 Aug 4;30(31):3404-15
– reference: 17483545 - Mol Hum Reprod. 2007 Jul;13(7):503-9
– reference: 19074548 - Mol Endocrinol. 2009 Feb;23(2):265-75
– reference: 19589872 - Endocrinology. 2009 Oct;150(10):4734-43
– reference: 12554859 - RNA. 2003 Feb;9(2):175-9
– reference: 20799954 - Mol Cancer. 2010;9:227
– reference: 21292970 - Science. 2011 Feb 4;331(6017):550-3
– reference: 9543141 - J Clin Endocrinol Metab. 1998 Apr;83(4):1201-5
– reference: 15541453 - Lancet. 2004 Nov 13-19;364(9447):1789-99
– reference: 18451233 - Clin Cancer Res. 2008 May 1;14(9):2690-5
– reference: 18941111 - Blood. 2009 Jan 8;113(2):396-402
– reference: 10087424 - Gynecol Obstet Invest. 1999;47 Suppl 1:18-20; discussion 20-2
– reference: 19651637 - Mol Hum Reprod. 2009 Oct;15(10):587-607
– reference: 18314120 - Fertil Steril. 2009 Mar;91(3):687-93
– reference: 7962366 - Hum Reprod. 1994 Jun;9(6):1001-2
– reference: 19692421 - Mol Hum Reprod. 2009 Oct;15(10):625-31
– reference: 12496258 - J Biol Chem. 2003 Mar 7;278(10):8508-15
– reference: 10499541 - Endocrinology. 1999 Oct;140(10):4809-20
– reference: 18710704 - Fertil Steril. 2009 May;91(5 Suppl):2148-56
– reference: 21266580 - J Biol Chem. 2011 Mar 25;286(12):10483-94
– reference: 19398263 - Cancer Lett. 2009 Oct 8;283(2):159-67
– reference: 18560586 - PLoS One. 2008;3(6):e2436
– reference: 19446316 - Gynecol Oncol. 2009 Aug;114(2):253-9
– reference: 17575287 - Hum Reprod Update. 2007 Sep-Oct;13(5):487-99
– reference: 15019828 - Fertil Steril. 2004 Mar;81 Suppl 1:904-11
– reference: 19683430 - Eur J Cancer. 2009 Sep;45(14):2618-27
– reference: 17175059 - Lung Cancer. 2007 Apr;56(1):25-33
– reference: 20103651 - Cancer Res. 2010 Feb 1;70(3):1063-71
SSID ssj0017258
Score 2.3437822
Snippet MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 136
SubjectTerms Adult
Blotting, Western
Cell Adhesion - genetics
Cell Adhesion - physiology
Cell Movement - genetics
Cell Movement - physiology
Cells, Cultured
Endometriosis - metabolism
Endometrium - cytology
Enzyme-Linked Immunosorbent Assay
Female
Humans
I-kappa B Kinase - metabolism
In Vitro Techniques
Interleukin-8 - genetics
Interleukin-8 - metabolism
MicroRNAs - genetics
MicroRNAs - metabolism
NF-kappa B - metabolism
Real-Time Polymerase Chain Reaction
Signal Transduction - genetics
Signal Transduction - physiology
Stromal Cells - cytology
Stromal Cells - metabolism
Young Adult
Title MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression
URI https://www.ncbi.nlm.nih.gov/pubmed/21989168
https://www.proquest.com/docview/923576144
https://pubmed.ncbi.nlm.nih.gov/PMC3292395
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbhMxELZCuXBBlPITKMgHyqXaZv93fUxCS0uUCqFW9BZ5194mgnijZBdUHoKH4Yh4hj4T459NnBIk6GW1mji2vPPt2OOd-QahVwkNvZQXmUPjMHPCKM8dGhTwXiUpAIrlxFUZcsPT-Pg8fHcRXbRav6yopbrKDvJvG_NKbqNVkIFeZZbsf2h22SkI4B70C1fQMFz_ScfDyQcZwkH3JUmmqOW2cZ8LVk65LsaxqOblVBKAyAO6ifhCF41ta8rzLOqZiYQVTbTAyWCw1z_c60nK1NMjR913e5KAdfyVaramueR75UxxTcw_8_rTRDipLBZgurJ3vMOm_q4pByhZNBXJrBUA8IaaHO2l5G2tDwyumpVVtlKNPprcNXNSIUM-Avuk4i8ZkJbxDWLXIUQzcB5wLQtBJr3OzRZ75dAr8-sFsbWSe5qo8o9FQhNoTWH6Y0nRcknnrq78YkFmNlWY8WVImacL_9zg5X4_7Ac-bI9JdAfd9cFJUQ79yWD5DSvxVXXY5awMwyuM3tFjd_TIio9aD7PJzbkZrWttf84eoPvGb8FdDcJt1OLiIdrpClqV0yv8GqtIYvWJZgd9b3CJV7jEFi6xwSWWuMQ2LrHBJbZwicsCxBwDLq9_dACR1z972KARAxqxQSNeQyNeofEROj86POsfO6buhzPzUrdyfM58L0_iIk5pkBa08DOfgOsdZlnipsQPCy9lYGMYrI2M54nLfJIRnxIZ3RBGLHiMtkQp-FOE3SSPmcsSL-EMQFRkUZQSRqGbLM3jPGkj3DzwEdhVOW0qeFkvRkTyQMnTkjZ6op__aKb5X0aNttooWdPMsoGkbF__RUzGirrdIObZrf_5HN1bvVq7aKua1_wFbIur7KVC329uW8Nx
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-199a+attenuates+endometrial+stromal+cell+invasiveness+through+suppression+of+the+IKK%CE%B2%2FNF-%CE%BAB+pathway+and+reduced+interleukin-8+expression&rft.jtitle=Molecular+human+reproduction&rft.au=Dai%2C+Lan&rft.au=Gu%2C+Liying&rft.au=Di%2C+Wen&rft.date=2012-03-01&rft.pub=Oxford+University+Press&rft.issn=1360-9947&rft.eissn=1460-2407&rft.volume=18&rft.issue=3&rft.spage=136&rft.epage=145&rft_id=info:doi/10.1093%2Fmolehr%2Fgar066&rft_id=info%3Apmid%2F21989168&rft.externalDocID=PMC3292395
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2407&client=summon